Neuroone Medical Technologies is trading 19.68% up at $2.25, with today’s move best attributed to healthcare-sector strength alongside broader risk appetite.
- No new company-specific announcement was identified for August 19, 2026.
- The latest catalyst was the August 13 fiscal third-quarter update, which reported 16% year-over-year product-revenue growth to $2.0 million and expanding gross margins.
- XLV is up 3.23%, supporting the sector-wide move.